Clinical trial
Feasibility Evaluation of the Embolic Agent BeadBlock™ in the Treatment of Uterine Fibroids With Uterine Artery Embolization With Comparison of Study Endpoints to Embosphere®
NCT00361036 is registered in ClinicalTrials.gov with Worthington-Kirsch, Robert L., M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Evaluation of the Embolic Agent BeadBlock™ in the Treatment of Uterine Fibroids With Uterine Artery Embolization With Comparison of Study Endpoints to Embosphere®
- Lead sponsor
- Worthington-Kirsch, Robert L., M.D.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2006
- Completion date
- March 31, 2010
- Enrollment
- 44 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.